S

Sona Nanotech Inc
CNSX:SONA

Watchlist Manager
Sona Nanotech Inc
CNSX:SONA
Watchlist
Price: 0.495 CAD 1.02% Market Closed
Market Cap: 55.8m CAD

Profitability Summary

Sona Nanotech Inc's profitability score is 37/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

37/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

37/100
Profitability
Score
37/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Sona Nanotech Inc

Revenue
0 CAD
Operating Expenses
-3.4m CAD
Operating Income
-3.4m CAD
Other Expenses
256.8k CAD
Net Income
-3.1m CAD

Margins Comparison
Sona Nanotech Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
CA
Sona Nanotech Inc
CNSX:SONA
54.1m CAD N/A N/A
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
13%
8%
US
Thermo Fisher Scientific Inc
NYSE:TMO
215.3B USD
18%
15%
US
Danaher Corp
NYSE:DHR
159.3B USD
19%
14%
CH
Lonza Group AG
SIX:LONN
36B CHF
15%
10%
US
Agilent Technologies Inc
NYSE:A
39.8B USD
21%
19%
US
IQVIA Holdings Inc
NYSE:IQV
37.8B USD
14%
8%
CN
WuXi AppTec Co Ltd
SSE:603259
260.9B CNY
30%
34%
KR
Samsung Biologics Co Ltd
KRX:207940
45.1T KRW
37%
29%
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
28%
21%
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.1B EUR
17%
9%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Sona Nanotech Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Sona Nanotech Inc
CNSX:SONA
54.1m CAD
-2 847%
-166%
-542%
-569%
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
3%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
215.3B USD
13%
7%
9%
8%
US
Danaher Corp
NYSE:DHR
159.3B USD
7%
4%
7%
5%
CH
Lonza Group AG
SIX:LONN
36B CHF
8%
4%
7%
5%
US
Agilent Technologies Inc
NYSE:A
39.8B USD
21%
11%
15%
13%
US
IQVIA Holdings Inc
NYSE:IQV
37.8B USD
20%
5%
11%
8%
CN
WuXi AppTec Co Ltd
SSE:603259
260.9B CNY
24%
18%
20%
15%
KR
Samsung Biologics Co Ltd
KRX:207940
45.1T KRW
14%
9%
15%
10%
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
-414%
24%
50%
29%
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.1B EUR
7%
3%
7%
5%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less